The 22q11.2 Society
www.22qsociety.org


Promoting research, diagnosis, prognosis, and management of 22q11.2DS & related disorders

Jacob Vorstman

Jacob Vorstman
Jacob Vorstman
Dr. Jacob Vorstman followed his studies in medicine at the Free University of Amsterdam, the Netherlands. He subsequently was trained as a child and adolescent psychiatrist. He conducted his PhD research on the molecular genetic and cognitive-behavioral aspects of the 22q11.2 deletion syndrome. In 2008, he defended his thesis successfully and was board certified as a psychiatrist.

Starting in 2000, Dr Vorstman has met numerous, mostly young patients with the 22q11.2 deletion syndrome, as part of the longitudinal 22q11.2DS psychiatry outpatient clinic he initiated. From 2004 to 2006, he worked in Professor Beverly Emanuel's lab at the Children's Hospital of Philadelphia, where he acquired the knowledge and skills of molecular genetic research.

In September 2017, Dr. Vorstman joined the Department of Psychiatry at the Hospital for Sick Children in Toronto as an Associate Professor. He continues to divide his time between his clinical work and his research activities. He is the P.I. of the 22q11.2DS lab at the Brain Center Rudolf Magnus, University Medical Center, Utrecht, and of two large genetic studies, one on autism within the Autism Genome Project (AGP), involving several EU/US partner sites, and one on schizophrenia. Furthermore, he is a co-investigator in a large European autism research consortium (EU-AIMS) and a senior investigator in several other research projects. To date, he has (co) published 40 research papers. Over the past years, he has been fortunate to develop close and productive collaborations with many investigators in the field of genetics of psychiatric disorders across the world.


Source: 22qsociety.org/about/advisors/advisors/content.asp?s=97&p=119&pv=1

The 22q11.2 Society Registered Charity No. 1165896